972-18-9 Usage
Chemical class
Piperidine derivatives, which are commonly used in the pharmaceutical industry for their various biological activities.
Potential uses
Anti-inflammatory and analgesic agent, making it a promising candidate for the development of new drugs for pain management.
Chemical structure
A piperidine ring with a benzyl group and a m-toluidino group attached, as well as a carbonitrile functional group.
Studied for treatment
Conditions such as arthritis and neuropathic pain.
Ongoing research
Unique structure and properties make it a subject of ongoing research in the pharmaceutical and medicinal chemistry fields.
Check Digit Verification of cas no
The CAS Registry Mumber 972-18-9 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 9,7 and 2 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 972-18:
(5*9)+(4*7)+(3*2)+(2*1)+(1*8)=89
89 % 10 = 9
So 972-18-9 is a valid CAS Registry Number.
InChI:InChI=1/C20H23N3/c1-17-6-5-9-19(14-17)22-20(16-21)10-12-23(13-11-20)15-18-7-3-2-4-8-18/h2-9,14,22H,10-13,15H2,1H3
972-18-9Relevant academic research and scientific papers
Inhibitors of prenyl-protein transferase
-
, (2008/06/13)
The present invention is directed to conformationally constrained compounds which inhibit prenyl-protein transferase and the prenylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting prenyl-protein transferase and the prenylation of the oncogene protein Ras.
INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE
-
, (2008/06/13)
The present invention is directed to compounds which inhibit farnesyl-protein transferase (FTase) and the farnesylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting farnesyl-protein transferase and the farnesylation of the oncogene protein Ras
